Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Rectal Neoplasms 9 Colorectal Neoplasms 6 Stomach Neoplasms 4 Prostatic Neoplasms 4 Endometrial Neoplasms 4 Neoplasms 3 Esophageal Neoplasms 3 Colonic Neoplasms 3 Uterine Cervical Neoplasms 2 Urinary Bladder Neoplasms 2 Thymoma 2 Obesity, Morbid 2 Lung Neoplasms 2 Kidney Neoplasms 2 Genital Diseases, Female 2 Uterine Prolapse 1 Uterine Neoplasms 1 Thyroid Neoplasms 1 Thyroid Cancer, Papillary 1 Surgery 1 Squamous Cell Carcinoma of Head and Neck 1 Robotic 1 Prostatic Diseases 1 Precancerous Conditions 1 Pelvic Organ Prolapse 1 Pancreatic Neuroendocrine Tumors 1 Pancreatic Neoplasms 1 Pancreatic Ductal Adenocarcinoma 1 Ovarian Neoplasms 1 Obesity, Abdominal 1

Interventions

Robotic Surgical Procedures 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Neoadjuvant Chemoimmunotherapy × Robotic Surgical Procedures × Clear all

NCT07528066 2026-04-14

DRAGON-NSCLC

Shanghai Chest Hospital

Neoadjuvant Chemoimmunotherapy

Data powered by HemOnc (CC BY 4.0) Colophon ⚡